A complete application in a minute — tailored resume and cover letter, ready to send.
Selatox Bio Pharma seeks aSupply Chain Supervisor for our GMP-certified facility in Cikarang, Indonesia. You will oversee demand planning, material control, inventory, and delivery coordination to ensure compliance with global pharmaceutical standards.
You will lead logistics and cold chain operations, coordinate import/export activities, and drive KPIs while collaborating with cross-functional teams to ensure business continuity and quality.
Would you like to learn about stringent global cGMP manufacturing standards?
We offer an opportunity to gain production know-how and technology meeting Korean cGMP standards at our GMP-certified manufacturing facility in Indonesia. Additionally, outstanding talents will have the chance to gain practical experience in Korea.
Our production facility in Cikarang boasts global-level manufacturing competitiveness with state-of-the-art automation, aseptic management, and quality tracking systems. Indonesian production personnel build expertise through rigorous training and hands‑on experience, and outstanding talents are offered opportunities to work at our headquarters in Korea. Currently, approximately 150 Indonesian production specialists are actively working in Korea. We are seeking talented individuals to join us at the forefront of the global pharmaceutical industry, creating fast, safe, and innovative medicines.
The Supply Chain Supervisor role involves overseeing supply chain and PPIC operations at our GMP-certified manufacturing facility in Cikarang, Indonesia. This position is central to ensuring compliance with global pharmaceutical standards and supporting our commitment to delivering high-quality products in the global pharmaceutical industry.
40 hours per week, 5 days
Sick leave, maternity leave, paternity leave, wedding leave, condolence leave, etc.
Min. 12 days for permanent employee (up to 24 based on tenure)
Founded in 1945, we are a global healthcare leader and the No.1 pharmaceutical company in Korea with over 4,500 employees. We operate 8 branches across Asia and the US, and maintain 5 R&D centers worldwide with 100+ partners globally. We have been recognized as an Outstanding Foreign Investment Company by the Indonesian Government (2022), awarded 'Best Workplace' in Asia (2023) and Korea (2022), and received recognition for Women-Friendly Corporate Culture & Diversity Management (2022).
Selatox Bio Pharma is Indonesia's first specialized botulinum toxin company, delivering high-quality products with global ambitions. Centered around our manufacturing facility in Cikarang and the UI R&D Center (Depok), we began full‑scale toxin production and research activities after completing the facilities in 2023. We aim to obtain GMP certification by 2026 and complete product registration in Indonesia by 2028. Through strategic partnerships with over 40 countries, we are accelerating our entry into the global market, with plans to establish ourselves as a trusted brand worldwide by 2030.
Application > Aptitude Test > 1st Interview > 2nd Interview > Compensation Negotiation > Final Onboarding
At Selatox, we place the highest priority on employee growth, providing an environment where you can work with autonomy and deep immersion. Regardless of age, tenure, gender, or nationality, we evaluate fairly, objectively, and transparently based on ability and performance, and reward accordingly. We strive to build a company where every employee feels a true sense of ownership. We believe our work becomes truly meaningful only when the growth of our people leads to the growth of our customers and society. This is what we call a true win‑win‑win. Selatox is a place full of opportunities for your growth. We look forward to sharing this journey of challenge and growth with you.
Hirer responsiveness Salary match Number of applicants
Your application will include the following questions:
Pharmaceuticals, Biotechnology & Medical Devices 51-100 employees
Selatox is Indonesia’s first dedicated botulinum toxin manufacturing facility, established in 2022 based on Daewoong’s FDA-approved facility standards in Korea. Located in Cikarang, Selatox completed construction in 2023 and is preparing for full‑scale production. We aim to obtain GMP certification by 2026, register products by 2028, and expand globally through partnerships in over 40 countries. Our vision is to deliver high-quality, halal-certified botulinum toxin — driving growth for Indonesia and the global market.
Selatox is Indonesia’s first dedicated botulinum toxin manufacturing facility, established in 2022 based on Daewoong’s FDA-approved facility standards in Korea. Located in Cikarang, Selatox completed construction in 2023 and is preparing for full‑scale production. We aim to obtain GMP certification by 2026, register products by 2028, and expand globally through partnerships in over 40 countries. Our vision is to deliver high-quality, halal-certified botulinum toxin — driving growth for Indonesia and the global market.